Update on geriatric cardiology;Actualización en cardiología geriátrica

Revista Espanola de Cardiologia

Volumn 63, Issue SUPPL. 1, 2010, Pages 17-28

  Martínez Sellés, Manuel ^a   Datino, Tomás ^a   Díaz Castro, Óscar ^b   López Palop, Ramón ^c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL DO MEIXOEIRO   (Spain)

^c HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

Author keywords

Elderly; Geriatric cardiology; Heart disease

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DABIGATRAN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DRONEDARONE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO; ROSUVASTATIN; WARFARIN; XIMELAGATRAN;

ACUTE CORONARY SYNDROME; AGED; AGING; ANGIOPLASTY; AORTA STENOSIS; BLEEDING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOLOGY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DEFIBRILLATOR; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; FRAIL ELDERLY; GERIATRIC PATIENT; GERIATRICS; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART CATHETERIZATION; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROGNOSIS; REVIEW; THROMBOEMBOLISM; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 77954123089     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(10)70137-8     Document Type: Article

References (68)

1. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, and P.A. Poole-Wilson Guía de práctica clínica de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (2008) Rev Esp Cardiol 61 2008 1329e1-e70
2. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration with the International Society for Heart and Lung Transplantation Circulation. 2009;119:e391-e479.
3. M. Anguita Sánchez, M.G. Crespo Leiro, E. De Teresa Galván, M. Jiménez Navarro, L. Alonso-Pulpón, and J. Muñiz García Prevalencia de la insuficiencia cardiaca en la población general española mayor de 45 años. Estudio PRICE Rev Esp Cardiol 61 2008 1041 1049
4. L. Djoussé, J.A. Driver, and J.M. Gaziano Relation between modifiable lifestyle factors and lifetime risk of heart failure JAMA 302 2009 394 400
5. A. Kalogeropoulos, V. Georgiopoulou, S.B. Kritchevsky, B.M. Psaty, N.L. Smith, and A.B. Newman Epidemiology of incident heart failure in a contemporary elderly cohort. The Health, Aging, and Body Composition Study Arch Intern Med 169 2009 708 715
6. S. Parashar, R. Katz, N.L. Smith, A.M. Arnold, V. Vaccarino, and N.K. Wenger Race, gender, and mortality in adults >65 years of age with incident heart failure (from the Cardiovascular Health Study) Am J Cardiol 103 2009 1120 1127
7. J. Afilalo, S. Karunananthan, M.J. Eisenberg, K.P. Alexander, and H. Bergman Role of frailty in patients with cardiovascular disease Am J Cardiol 103 2009 1616 1621
8. O. Miró, P. Llorens, F.J. Martín-Sánchez, P. Herrero, J. Pavón, and M.J. Pérez-Durá Factores pronósticos a corto plazo en los ancianos atendidos en urgencias por insuficiencia cardiaca aguda Rev Esp Cardiol 62 2009 757 764
9. K.F. Adams Jr., J.H. Patterson, R.M. Oren, M.R. Mehra, C.M. O'Connor, I.L. Piña STAMINA-HFP Registry Investigators Prospective assessment of the occurrence of anemia in patients with heart failure: Results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry Am Heart J 157 2009 926 932
10. H.F. Groenveld, J.L. Januzzi, K. Damman, J. Van Wijngaarden, H.L. Hillege, and D.J. Van Veldhuisen Anemia and mortality in heart failure patients a systematic review and meta-analysis J Am Coll Cardiol 52 2008 818 827
11. A. Kazory, and E.A. Ross Anemia: The point of convergence or divergence for kidney disease and heart failure? J Am Coll Cardiol 53 2009 639 647
12. W.H. Tang, W. Tong, A. Jain, G.S. Francis, C.M. Harris, and J.B. Young Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure J Am Coll Cardiol 51 2008 569 576
13. J.K. Ghali, I.S. Anand, W.T. Abraham, G.C. Fonarow, B. Greenberg, and H. Krum Randomized double-blind trial of darbopoetin alfa in patients with symptomatic heart failure and anemia Circulation 117 2008 526 535
14. RED-HFTM Trial -Reduction of Events With Darbepoetin Alfa in Heart Failure Trial [citado 1 Sep 2009] Disponible en: http://clinicaltrials.gov/ct/ show/NCT00358215
15. M. Pfisterer, P. Buser, H. Rickli, M. Gutmann, P. Erne, and P. Rickenbacher BNP-guided vs symptom-guided heart failure therapy (TIME-CHF) randomized trial. The Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure JAMA 301 2009 383 392
16. G.M. Felker, V. Hasselblad, A.F. Hernández, and C.M. O'Connor Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials Am Heart J 158 2009 422 430
17. M. Komajda, O. Hanon, M. Hochadel, J.L. López-Sendón, F. Follath, and P. Ponikowski Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II Eur Heart J 30 2009 478 486
18. C.W. Yancy, G.C. Fonarow, N.M. Albert, A.B. Curtis, W.G. Stough, and M. Gheorghiade Influence of patient age and sex on delivery of guideline- recommended heart failure care in the outpatient cardiology practice setting: Findings from IMPROVE HF Am Heart J 157 2009 754-62.e2.
19. F.A. McAlister, N. Wiebe, J.A. Ezekowitz, A.A. Leung, and P.W. Armstrong Meta-analysis: B-blocker dose, heart rate reduction, and death in patients with heart failure Ann Intern Med 150 2009 784 794
20. D.J. Van Veldhuisen, A. Cohen-Solal, M. Böhm, S.D. Anker, D. Babalis, and M. Roughton Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure) J Am Coll Cardiol 53 2009 2150 2158
21. M. Martínez-Sellés, T. Datino, M.A. Gómez Sánchez, and C. Bañuelos Actualización en cardiología geriátrica Rev Esp Cardiol 61 Supl 1 2008 4 14
22. M. Martínez-Sellés, R. López-Palop, T. Datino, and C. Bañuelos Actualización en cardiología geriátrica Rev Esp Cardiol 62 Supl 1 2009 53 66
23. J. Mant, F.D. Hobbs, K. Fletcher, A. Roalfe, D. Fitzmaurice, and G.Y. Lip Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503 (Pubitemid 47212371)
24. D. Poli, E. Antonucci, E. Grifoni, R. Abbate, G.F. Gensini, and D. Prisco Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years J Am Coll Cardiol 54 2009 999 1002
25. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, and A. Parekh Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 DOI: 10.1056/ NEJMoa0905561.
26. D.R. Holmes, V.Y. Reddy, Z.G. Turi, S.K. Doshi, H. Sievert, M. Buchbinder PROTECT AF Investigators Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 2009 534 542
27. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
28. I.C. Van Gelder, V.E. Hagens, H.A. Bosker, J.H. Kingma, O. Kamp, and T. Kingma A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840
29. D.G. Wyse, A.L. Waldo, J.P. DiMarco, M.J. Domanski, Y. Rosenberg, and E.B. Schron A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
30. D. Roy, M. Talajic, S. Nattel, D.G. Wyse, P. Dorian, and K.L. Lee Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677
31. B.N. Singh, S.J. Connolly, H.J. Crijns, D. Roy, P.R. Kowey, and A. Capucci Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter N Engl J Med 357 2007 987 999
32. S.H. Hohnloser, H.J. Crijns, M. Van Eickels, C. Gaudin, R.L. Page, and C. Torp-Pedersen Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
33. Sanofi-Aventis (Paris Bourse: EURONEXT: SAN; and NewYork: NYSE: SNY) Press Release DIONYSOS Study Results Showed the Respective Profiles of Dronedarone and Amiodarone. Paris, December 23, 2008.
34. J.M. Davy, M. Herold, C. Hoglund ERATO Study Investigators Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the efficacy and safety of dronedarone for the control of ventricular rate during atrial fibrillation (ERATO) study Am Heart J 156 2008 527e1-9
35. E.R. Ellis, S.D. Culler, A.W. Simon, and M.R. Reynolds Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries Heart Rhythm 6 2009 1267 1273
36. I. Cygankiewicz, J. Gillespie, W. Zareba, M.W. Brown, I. Goldenberg, H. Klein MADIT II Investigators Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators Heart Rhythm 6 2009 468 473
37. D.T. Huang, H.W. Sesselberg, S. McNitt, K. Noyes, M.L. Andrews, W.J. Hall for the MADIT-II Research Group Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II Substudy J Cardiovasc Electrophysiol 18 2007 833 838
38. A. Epstein, G.N. Kay, V.J. Plumb, H.T. McElderry, H. Doppalapudi, T. Yamada for the ACT Investigators Implantable cardioverter-defibrillator prescription in the elderly Heart Rhythm 6 2009 1136 1143
39. A.J. Moss, W.J. Hall, D.S. Cannom, H. Klein, M.W. Brown, and J.P. Daubert Cardiac-Resynchronization therapy for the prevention of heart-failure events N Engl J Med 2009 Sep 1 [Epub ahead of print].
40. Van Bommel RJ, Bax JJ, Abraham WT, Chung ES, Pires LA, Tavazzi L, et al. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J. doi:10.1093/ eurheartj/ehp368.
41. W.J. Ehlenbach, A.E. Barnato, J.R. Curtis, W. Kreuter, T.D. Koepsell, and R.A. Deyo Epidemiologic study of in-hospital cardiopulmonary resuscitation in the elderly N Engl J Med 361 2009 22 31
42. A. Rashidi, A.R. Sehgal, M. Rahman, and A.S. O'Connor The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years Am J Cardiol 102 2008 1668 1673
43. K.M. Eggers, L. Lind, P. Venge, and B. Lindahl Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction? Am J Cardiol 103 2009 588 591
44. M. Martínez-Sellés, M.T. Vidán, R. López-Palop, L. Rexach, E. Sánchez, and T. Datino El anciano con cardiopatía terminal Rev Esp Cardiol 62 2009 409 421
45. F. Schiele, N. Meneveau, M.F. Seronde, V. Descotes-Genon, J. Oettinger, and F. Ecarnot Changes in management of elderly patients with myocardial infarction Eur Heart J 30 2009 987 994
46. J.A. Ezekowitz, P. Kaul, J.A. Bakal, P.W. Armstrong, R.C. Welsh, and F.A. McAlister Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction J Am Coll Cardiol 53 2009 13 20
47. Z. Zhao, J. Geng, Z.M. Ge, W. Wang, Y. Zhang, and W.Q. Kang Efficacy and safety of atorvastatin during early hospitalization in elderly patients with unstable angina Clin Exp Pharmacol Physiol 36 2009 554 558
48. A. Iversen, J.S. Jensen, H. Scharling, and P. Schnohr Hypercholesterolaemia and risk of coronary heart disease in the elderly: impact of age: the Copenhagen City Heart Study Eur J Intern Med 20 2009 139 144
49. Glynn R, Ridker PM, on behalf of the JUPITER Trial Study Group. Randomized evidence on Rosuvastatin for primary prevention in individuals 70 years of age or older. JUPITER. Clinical Trial Update II. European Society of Cardiology 2009 Congress. Barcelona, 2009.
50. A.M. From, C.S. Rihal, R.J. Lennon, D.R. Holmes, and A. Prasad Temporal trends and improved outcomes of percutaneous coronary revascularization in nonagenarians JACC Cardiovasc Interv 1 2008 692 698
51. H. Ouldzein, J. Roncalli, W. Zouaoui, V. Bongard, N. Boudou, and N. Dumonteil Drug-eluting or bare-metal stents in subjects over 75 years of age: what is the best therapeutic strategy? Data from 460 consecutive patients with 1-year outcome Cardiovasc Revasc Med 10 2009 94 102
52. P.S. Douglas, J.M. Brennan, K.J. Anstrom, A. Sedrakyan, E.L. Eisenstein, and G. Haque Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry J Am Coll Cardiol 53 2009 1629 1641
53. A. Sanfilippo, M. Cumbo, A.M. Caggegi, S. Monaco, R. Bucalo, and C. Ruperto Long-term outcomes comparison of different types of DES in elderly patients from a real-world experience J Invasive Cardiol 21 2009 330 333
54. J. Rodes-Cabau, J. Deblois, O.F. Bertrand, S. Mohammadi, J. Courtis, and E. Larose Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians Circulation 118 2008 2374 2381
55. A.J. Bagnall, S.G. Goodman, K.A. Fox, R.T. Yan, J.M. Gore, and A.N. Cheema Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes Am J Cardiol 103 2009 1530 1536
56. R.D. Lopes, K.P. Alexander, S.V. Manoukian, M.E. Bertrand, F. Feit, and H.D. White Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol 53 2009 1021 1030
57. S. Zimmermann, S. Ruthrof, K. Nowak, L. Klinghammer, J. Ludwig, and W.G. Daniel Outcomes of contemporary interventional therapy of ST elevation infarction in patients older than 75 years Clin Cardiol 32 2009 87 93
58. P. Shah, A.H. Najafi, J.A. Panza, and H.A. Cooper Outcomes and quality of life in patients>or=85 years of age with ST-elevation myocardial infarction Am J Cardiol 103 2009 170 174
59. H.S. Lim, O. Farouque, N. Andrianopoulos, B.P. Yan, C.C. Lim, and A.L. Brennan Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock JACC Cardiovasc Interv 2 2009 146 152
60. Bueno H, Alonso J, Betriu A, Cequier A, García E, Heras M, et al. Primary angioplasty versus fibrinolysis in the very elderly. The TRIANA Study. Hot Line II European Society of Cardiology 2009 Congress. Barcelona, 2009.
61. A. Dziewierz, Z. Siudak, T. Rakowski, M. Chyrchel, W. Mielecki, and M. Janzon Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients transferred with ST-elevation myocardial infarction Data from the EUROTRANSFER registry Int J Cardiol 2009 Jun 24 [Epub ahead of print].
62. C. Naughton, R.O. Feneck, and J. Roxburgh Early and late predictors of mortality following on-pump coronary artery bypass graft surgery in the elderly as compared to a younger population Eur J Cardiothorac Surg 2009 Jun 17 [Epub ahead of print].
63. X. Chen, X. Chen, D. Xie, F. Meng, K. Shi, and M. Xu Radial artery as conduit is safe and effective in coronary bypass surgery in the elderly: single-central results from 326 patients Circ J 73 2009 1049 1054
64. B. Zingone, G. Gatti, E. Rauber, P. Tiziani, L. Dreas, and A. Pappalardo Early and late outcomes of cardiac surgery in octogenarians Ann Thorac Surg 87 2009 71 78
65. S. Leontyev, T. Walther, M.A. Borger, S. Lehmann, A.K. Funkat, and A. Rastan Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE Ann Thorac Surg 87 2009 1440 1445
66. J.G. Webb, L. Altwegg, R.H. Boone, A. Cheung, J. Ye, and S. Lichtenstein Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes Circulation 119 2009 3009 3016
67. N. Al-Attar, D. Himbert, F. Descoutures, B. Iung, R. Raffoul, and D. Messika-Zeitoun Transcatheter aortic valve implantation: selection strategy is crucial for outcome Ann Thorac Surg 87 2009 1757 1762
68. D. Himbert, F. Descoutures, N. Al-Attar, B. Iung, G. Ducrocq, and D. Detaint Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis J Am Coll Cardiol 54 2009 303 311